Amanote Research
Register
Sign In
Rationale, Design, and Baseline Characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: A Pragmatic Randomized Controlled Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Contrast-Induced Nephropathy
Trials
- United Kingdom
doi 10.1186/1745-6215-10-38
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Pharmacology
Date
June 4, 2009
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
The Standard Dose Versus Double Dose of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy; A Randomized Controlled Clinical Trial
Journal of Nephropathology
Nephrology
Ischemic Preconditioning for Prevention of Contrast Medium-Induced Nephropathy: Randomized Pilot RenPro Trial (Renal Protection Trial)
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Is There Sufficient Evidence to Support the Use of Intravenous N-Acetylcysteine for the Prevention of Contrast Induced Nephropathy?
Journal of pharmacology & clinical research
Contrast-Induced Nephropathy
Retrospective Analysis of the Efficacy of Radio-Contrast-Induced Nephropathy Prophylaxis
Critical Care
Critical Care
Intensive Care Medicine
The High Risk of Contrast-Induced Nephropathy in Patients With Suspected Pulmonary Embolism Despite Three Different Prophylaxis: A Randomized Controlled Trial
Academic Emergency Medicine
Medicine
Emergency Medicine
The Choice of the Iodinated Radiographic Contrast Media to Prevent Contrast-Induced Nephropathy
Advances in Nephrology
A Prospective Study on Prevention of Contrast – Induced Nephropathy in Croatia
Medicina Fluminensis
Medicine
Serum Osmolarity and Contrast-Induced Nephropathy
Angiology
Cardiovascular Medicine
Cardiology
